BXBilin Xu

Bilin Xu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Bilin Xu has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • Chi-Tang Ho

    Department of Food Science, Rutgers University, New Brunswick, NJ 08901, USA

    1 shared publication
  • Famin Ke

    Green Pharmaceutical Technology Key Laboratory of Luzhou, Department of Microbial and Biochemical Pharmacy, School of Pharmacy, Southwest Medical University, Luzhou, China

    1 shared publication
  • Haixia Peng

    Green Pharmaceutical Technology Key Laboratory of Luzhou, Department of Microbial and Biochemical Pharmacy, School of Pharmacy, Southwest Medical University, Luzhou, China

    1 shared publication
  • Hongyuan Tan

    College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China

    1 shared publication
  • Jianfeng Zhan

    College of Biology and Agricultural Resources, Huanggang Normal University, Huanggang 438000, China

    1 shared publication
  • Jing Zhang

    Green Pharmaceutical Technology Key Laboratory of Luzhou, Department of Microbial and Biochemical Pharmacy, School of Pharmacy, Southwest Medical University, Luzhou, China

    1 shared publication

Latest Publications

  • Identification and characterization of a versatile keratinase, KerZJ, from Stenotrophomonas sp. LMY

    by Haixia Peng, Manyu Liang, Jing Zhang, Wenbo Liu, Yanhong Yang, Yingjie Sun, Famin Ke, Yijiao Wen, Siyuan Liu, Bilin Xu, et al.

    Keratinases have drawn increasing attention in recent decades owing to their catalytic versatility and broad applications from agriculture to medicine. In the present study, we isolated a highly keratinolytic and fibrinolytic bacterium from the campus soil and named it Stenotrophomonas sp. LMY based on genetic information. To identify the potential keratinase genes, the genome sequence of the strain was obtained and analyzed. Sequence alignment and comparison revealed that the protein 1_737 (KerZJ) had the highest sequence homology to a reported keratinase KerBL. We recombinantly expressed KerZJ in Escherichia coli Origami™ (DE) pLysS and purified it to homogeneity. KerZJ showed the highest activity at 40 °C and pH 9.0, and metal ions exhibited no significant effects on its activity. Although reducing agents would break the disulfide bonds in KerZJ and reduce its activity, KerZJ still exhibited the ability to hydrolyze feather keratin in the presence of β-ME. KerZJ could efficiently digest human prion proteins. In addition, KerZJ showed fibrinolytic activity on fibrin plates and effectively eliminated blood clots in a thrombosis mouse model without side effects. Our results suggest that KerZJ is a versatile keratinase with significant potential for keratin treatment, decontamination of prions, and fibrinolytic therapy.


  • Open Access

    Bioactives of Momordica charantia as Potential Anti-Diabetic/Hypoglycemic Agents

    by Bilin Xu, Zhiliang Li, Ting Zeng, Jianfeng Zhan, Shuzhen Wang, Chi-Tang Ho, Shiming Li

    Momordica charantia L., a member of the Curcubitaceae family, has traditionally been used as herbal medicine and as a vegetable. Functional ingredients of M. charantia play important roles in body health and human nutrition, which can be used directly or indirectly in treating or preventing hyperglycemia-related chronic diseases in humans. The hypoglycemic effects of M. charantia have been known for years. In this paper, the research progress of M. charantia phytobioactives and their hypoglycemic effects and related mechanisms, especially relating to diabetes mellitus, has been reviewed. Moreover, the clinical application of M. charantia in treating diabetes mellitus is also discussed, hoping to broaden the application of M. charantia as functional food.